This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Akihiko Mizoroki
Senior Principal Scientist at Chugai Pharmabody Research


Akihiko Mizoroki is a Senior Principal Scientist in Chugai Pharmabody Research(CPR) that is located in Singapore. At CPR, he is responsible for development of the novel technology for cell selective agonists. Before moving to CPR, he spent 12 years at Chugai Pharmaceutical Company and worked as a leader for several drug discovery projects including the antibody against HLA-DQ2.5 and gluten peptide complexes.

Agenda Sessions

  • A Novel Antibody Targeting the HLA-DQ2.5/Gluten Peptide Complex with Broad Cross-reactivity and Selectivity